Variability of antigenic epitopes of the fusion protein of Newcastle disease virus

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 21, Issue 1, 1998, Pages 51-63

  Panshin, A ^a   Shihmanter, E ^a   Weisman, Y ^a   Orvell C ^b   Lipkind, M ^a  

^a KIMRON VETERINARY INSTITUTE   (Israel)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antigenic epitopes; Fusion protein; Monoclonal antibodies; Newcastle disease virus; Radio immuneprecipitation assay

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS FUSION PROTEIN;

ARTICLE; NEWCASTLE DISEASE PARAMYXOVIRUS;

AVES; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE; RNA VIRUSES; VICTORIA;

EID: 0031922806     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9571(97)00016-7     Document Type: Article

References (40)

1. Morrison T. and Portner A. Structure, function, and intracellular processing of the glycoproteins of paramyxoviridae. In The Paramyxoviruses. D. W. Kingsbury (Ed.). Plenum Press, New York, pp. 347-482 (1991).
2. Choppin P. V., Scheid A. The role of viral glycoproteins in adsorption, penetration and pathogenicity of viruses. Rev. Infect. Dis. 2:1980;40-61.
3. Galinski M. S. and Wechsler S. L. Molecular biology of paramyxovirus. In The Paramyxoviruses. D. W. Kingsbury (Ed.). Plenum Press, New York, pp. 41-82 (1991).
4. Paterson R. G., Shaughnessy M. A., Lamb R. A. Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide. J. Virol. 63:1989;1293-1312.
5. Klenk H.-D. and Garten W. Activation cleavage of viral spike proteins by host proteases. In Cellular Reception for Animal Viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp. 241-280 (1994).
6. Merz D. C., Scheid A., Choppin P. W. Importence of antibodies to the fusion glycoproteins in the prevention of spread of infection. J. Exp. Med. 151:1981;275-288.
7. Meulemans G., Gonze M., Carlier M. C., Petit P., Burny A., Long L. Protective effects of HN and F glycoprotein-specific monoclonal antibodies on experimental Newcastle disease. Avian Pathol. 15:1986;761-768.
8. Umino Y., Kohama T., Kahase M., Sugiura A., Klenk H.-D., Rott R. Protective effect of antibodies to two viral envelope glycoproteins on lethal infection with Newcastle disease virus. Arch. Virol. 71:1987;97-108.
9. Sato H., Oh-hira M., Ishida N., Imamura Y., Hattori S., Kawakita M. Molecular cloning and nucleotide sequence of P, M and F genes of Newcastle disease virus avirulent strain D26. Virus Res. 7:1987;241-255.
10. Iritani Y., Aoyama S., Hayashi Y., Mori H., Tawara H., Matsubara F., Kamogawa K. Biopotency of inactivated subunit vaccine of Newcastle disease virus fusion protein produced by gene transfer using a hybrid baculovirus vector in Bombyxmori mori pupae. Jap. Poult. Sci. 32:1995;42-46.
11. Kamiya N., Niikura M., Ono M., Kai C., Matsuura Y., Mikami T. Protective effect of individual glycoproteins of Newcastle disease virus expressed in insect cells: the fusion protein derived from an avirulent strain had lower protective efficacy. Virus Res. 32:1994;373-379.
12. Letellier C., Burny A., Meulemans G. Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge. Arch. Virol. 118:1991;43-56.
13. Meulemans G., Letellier C., Gonze M., Carlier M. C., Burny A. Newcastle disease virus F glycoprotein expressed from a recombinant vaccinia virus vector protects chickens against live virus challenge. Avian Pathol. 17:1988;821-827.
14. Mori H., Tawara H., Nakazawa H., Sumida M., Matsubara F., Aoyama S., Iritani Y., Hayashi Y., Kamogawa K. Expression of the Newcastle disease virus (NDV) fusion glycoprotein and vaccination against NDV challenge with a recombinant baculovirus. Avian Dis. 38:1994;772-777.
15. Murakami Y., Kagino T., Niikura M., Mikami T., Ishii K., Matsuura Y. Characterization of Newcastle disease virus envelope glycoproteins expressed in insect cells. Virus Res. 33:1994;123-137.
16. Taylor J., Edbauer C., Rey Senelonge A., Bouquet J. F., Norton E., Goebel S., Desmettre P., Paoletti E. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J. Virol. 64:1990;1441-1450.
17. Pringle C. R. The genetics of Paramyxoviruses. In The Paramyxoviruses. D. W. Kingsbury (Ed.). Plenum Press, New York, pp. 1-39 (1991).
18. Abenes G., Kida H., Yanagawa R. Antigenic mapping and functional analysis of the F protein of Newcastle disease virus using monoclonal antibodies. Arch. Virol. 90:1986;97-110.
19. Collins M. S., Bashiruddin J. B., Alexander D. J. Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease viruses showing variation in antigenicity and pathogenicity. Arch. Virol. 128:1993;363-370.
20. Meulemans G., Gonze M., Carlier M. C., Petit P., Burny A., Le Long Evalution of the use of monoclonal antibodies to hemagglutinin and fusion glycoproteins of Newcastle disease virus for virus identification and strain differentiation purposes. Arch. Virol. 92:1987;55-62.
21. Rota J. S., Heath J. L., Rota P. A., King G. E., Celma M. L., Carabana J., Fernandez-Munoz R., Brown D., Jin L., Bellini W. J. Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J. Infect. Dis. 173:1996;32-37.
22. Rota J. S., Wang Z. D., Rota P. A., Bellini W. J. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res. 31:1994;317-330.
23. Rota J. S., Hummel K. B., Rota P. A., Bellini W. J. Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology. 188:1992;135-142.
24. Russell P. H., Alexander D. J. Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies. Arch. Virol. 75:1983;243-253.
25. Rivetz B., Lipkind M. Interaction of Newcastle disease virus strains differing in virulence with chicken red blood cell receptors. Arch. Virol. 85:1985;231-255.
26. Iorio R. M., Bratt M. A. Monoclonal antibodies to Newcastle disease virus: delineation of four epitopes on the HN glycoprotein. J. Virol. 48:1983;440-450.
27. Orvell C., Grandien M. The effects of monoclonal antibodies of structural proteins of Sendai virus. J. Immunol. 129:1982;2779-2787.
28. Panshin A., Shihmanter E., Orvel C., Weisman Y. and Lipkind M. Characterization of Newcastle disease virus field strains by means of three panels of monoclonal antibodies: analysis of variation regularities. In Immunobiology of Viral Infections. M. Schwyzer and M. Ackermann (Eds). roc. 3nd Congress Europ. Soc. Vet. Virol., pp. 475-478 (1995).
29. Li Y. L., Song W. J., Han J. J., Ruppel A. Detection of Schistosoma japonicum antigen (Sj31/32) in sera of Chinese patients using a sandwich ELISA based on monoclonal antibody. Trop. Med. Parasitol. 45:1994;115-118.
30. Harlow E. and Lane D. (Eds) Labelling antibodies. In Antibodies. A Laboratory Manual, Cold Spring Harbor Laboratory, USA, pp. 340-342 (1988).
31. Nishikawa K., Isomura S., Suzuki S., Watanabe E., Hamaguchi M., Yoshida T., Nagai Y. Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons. Virology. 130:1983;318-330.
32. Nishikawa K., Hanada N., Morishima T., Yoshida T., Hamaguchi M., Toyoda T., Nagai Y. Antigenic characterization of the internal proteins of Newcastle disease virus by monoclonal antibodies. Virus Res. 7:1987;83-92.
33. Paton D. J., Sands J. J., Roehe P. M. BVD monoclonal antibodies: relationship between viral protein specificity. Arch. Virol. 3:1991;47-54.
34. Samson A. S. R. Anomalous behavior of Newcastle disease virus haemagglutinin-neuraminidase protein in Western blotting analysis of monoclonal antibody binding sites. J. Gen. Virol. 67:1986;1199-1203.
35. Long L., Portetelle D., Ghysdael J., Gonze M., Burny A., Meulemans G. Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycosylation and reactivity. J. Virol. 57:1986;1198-1202.
36. Umino Y., Kohama T., Sato T. A., Sugiura A., Klenk H.-D., Rott R. Monoclonal antibodies to three structural proteins of Newcastle disease virus: biological characterization of the change of envelope glycoproteins associated with proteolytic cleavage. J. Gen. Virol. 71:1990;1189-1197.
37. Iorio R. M., Glickman R. L., Riel A. M., Sheehan J. P., Bratt M. A. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment. Virus Res. 13:1989;245-262.
38. Russell P. H., Samson A. C. R. and Alexander D. J. Newcastle disease virus variation. In Applied Virology Research. E. Kurstak, R. G. Marusyk, F. A. Murphy and M. H. Van Regenmortel (Eds). pp. 179-195 (1990).
39. Yusoff K., Nesbit M., McCartney H., Meulemans G., Alexander D. J., Collins M. S., Emmerson P. T., Samson A. C. R. Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C. J. Gen. Virol. 70:1989;3105-3109.
40. Norrby E. Immunobiology of paramyxoviruses. In The Paramyxoviruses. D. W. Kingsbury (Ed.). Plenum Press, New York, pp. 481-508 (1991).